Member Info for Cwalsh

I’m curious about what he said. All I knew was he retired after three weeks.

TKevin , GDR products aren’t medicines requiring FDA trials, they fall under the medical IVDs category. I believe they’re in the final stages of submission.

Haha Emerald, you were here a couple of years ago for a quick punt and you ended up losing it and become LTH 😂😂😂

Mikodx, they said “around June 2026 upon completion of ongoing studies”. Don’t just assume , read between the lines.

Ha ha 1£ 😄😄, 5p this time next year is dream come true for many .

What’s your average ??

@Garonne, GDR said The application will be “around June 2026” so it could be mid-July. However, the FDA takes a week to acknowledge it.

Nissan , Have u had too many drinks last night ??

Ha ha , big buys :-) .

If the submission is due any minute then board friends and relatives must have piled in with big by now . The volume is very very low since few days .

Roger, the market doesn’t believe anything GDR says or does. I still say 3p by the end of July 2027.

A likely reason for the delay is the reduction in staff which has led to fewer resources and consequently more delays.

AI review .

Compare the wording across RNS:

• December 2025 (Final Results): submission “anticipated around June 2026” — flat statement

• February 2026 (fundraise RNS): “anticipated around June 2026, with a 3-4 month review period”

• 30 March 2026 (Interim Results): “FDA 510(k) submission for Genedrive CYP2C19 currently anticipated around June 2026, pending completion of studies, with an expected 3-4 month review period post submission”

That “pending completion of studies” qualifier is new and is the tell. It wasn’t in the earlier announcements. They’ve added a conditionality clause to what was previously presented as a settled date. That’s the company quietly hedging a deadline it’s no longer confident it’ll hit

Haha, yes, his £273 purchase went through this morning alongside Amers massive £76 trade.

This is pathetic, it’s a clear sign the market doesn’t believe in Genedrive and its BOD. It’s the beginning of the end .

Nissan, Trusting Britishbulls? It’s a comedy piece. A satirical website .

They said June but I’ll give them the benefit of the doubt until the end of June.

I know what’s happening and I’m amazed.

Amer will be buying millions of shares. Keep an eye on the 100k and 200k shares.

EC , The board is failing to commercialise the golden opportunity. My concern is no longer whether the science works, but whether the company can actually commercialize it.

Under Section 303 of the Companies Act 2006, shareholders have the legal right to force the company to call an Extraordinary General Meeting (EGM) to vote on removing directors.

The Requirement: You must assemble a group of shareholders who collectively hold at least 5% of the paid-up voting share capital of the company.

I now own 2% and wish I could buy another 3% to call a meeting.

Garonne , Genedrive is arguably the most incompetent and relaxed on the market. Credo Diagnostic, however, entered the scene with their own assay and is already widely available online. GDR has used the same assay for years yet has never shown any sense of urgency. They should ditch their “novel test” label altogether. What a waste of time.

https://www.credodxbiomed.com/our-products/vitasiro-solo/vitasiro-solo-mt-rnr1-snp-assay/